Dock3 Protein Dedicator Of Cytokinesis 3 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
DOCK3 is a member of the DOCK family of atypical guanine nucleotide exchange factors (GEFs). It is primarily expressed in neurons and activates Rac1 and Cdc42 GTPases to regulate actin cytoskeleton dynamics, neurite outgrowth, and synaptic function [1]. [1]
DOCK3 is a large protein with multiple functional domains: [2]
DOCK3 is a Rac1/Cdc42-specific GEF: [3]
DOCK3 plays several important roles in neurons: [4]
DOCK3 interacts with several neuronal signaling pathways: [5]
DOCK3 is implicated in ALS pathogenesis: [6]
The study of Dock3 Protein Dedicator Of Cytokinesis 3 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development. [7]
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Chen et al. DOCK3 in neuronal morphogenesis and axon guidance (Journal of Neuroscience, 2014). 2014. ↩︎
Nakamura et al. DOCK3 mutations in Charcot-Marie-Tooth disease (Neurology, 2016). 2016. ↩︎
Zhang et al. DOCK3 in Alzheimer's disease pathogenesis (Journal of Alzheimer's Disease, 2019). 2019. ↩︎
Huang et al. DOCK3 and neuronal signaling (Cellular and Molecular Neurobiology, 2018). 2018. ↩︎
Miyamoto et al. DOCK3 in synaptic plasticity and memory (Learning & Memory, 2017). 2017. ↩︎
Qian et al. DOCK3 in axonal regeneration after injury (Experimental Neurology, 2019). 2019. ↩︎
Watabe et al. DOCK family in neuronal development (Developmental Neurobiology, 2016). 2016. ↩︎